Get the Stockscreener App
0.01
23.29%
-0.0049
Cero Therapeutics Holdings Inc stock is traded at $0.01, with a volume of 125.88K.
It is down -23.29% in the last 24 hours and up +7.83% over the past month.
CERO TERAPEUTICS HLDG INC
See More
Previous Close:
$0.0149
Open:
$0.0115
24h Volume:
125.88K
Relative Volume:
2.33
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-20.70M
P/E Ratio:
-0.000136
EPS:
-73.3042
Net Cash Flow:
$-14.40M
1W Performance:
-23.29%
1M Performance:
+7.83%
6M Performance:
-99.97%
1Y Performance:
-100.00%
1-Day Range:
$0.00968
$0.0115
1-Week Range:
$0.0101
$0.0115
52-Week Range:
$0.01
$0.0149
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Name
Cero Therapeutics Holdings Inc
Sector
Industry
Phone
-
Address
-
Compare CERO vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
0.01 | 0 | 0 | -20.70M | -14.40M | -73.30 |
VRTX
Vertex Pharmaceuticals Inc
|
517.47 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.55 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
995.02 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
134.53 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.90 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Upgrade | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc Stock (CERO) Latest News
BTAIQ Stock Price and Chart — OTC:BTAIQ - TradingView
SRx Health Solutions Secures Major CERo Financing Deal - TipRanks
SRX Global (SRXH) lines up $11.7M for CERo, backed by its cell therapy assets - Stock Titan
CERo Therapeutics Holdings Secures New Consolidated Financing Facility - TipRanks
CERo Therapeutics (CERO) folds $5.7M debt into 10% secured note due Oct 2026 - Stock Titan
CERo Therapeutics Secures Up to $11.67 Million SRX Financing, Consolidates $5.67 Million Debt - TradingView
BCAB Stock Price and Chart — OTC:BCAB - TradingView
SRX Global Acquires Senior Secured Debt in CERo - GlobeNewswire
SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers - Yahoo Finance
CERo Therapeutics Holdings, Inc. announced that it has received $6 million in funding from SRx Health Solutions Inc. - marketscreener.com
Price to earnings forward of CERo Therapeutics Holdings, Inc. – OTC:CEROW - TradingView
CERo Therapeutics (CERO) warns on going concern as losses mount and deficit widens - Stock Titan
CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Cero Therapeutics (CERO) holder Isaiah Tibbs reports 4.63% ownership stake - Stock Titan
CERo Therapeutics Holdings, Inc. Revenue Breakdown – OTC:CERO - TradingView
CERo Therapeutics Holdings, Inc. Revenue Breakdown – OTC:CEROW - TradingView
CERo Therapeutics Expands Convertible Debt Financing Arrangement - TipRanks
CERO Therapeutics (OTCQB: CERO) details $2,606,500 discounted convertible note funding - Stock Titan
Cero Therapeutics Secures $2.09M 10% Convertible Note With SRX Global, Maturing May 2027 - TradingView
CERO Therapeutics (CERO) details $2,085,200 10% convertible note deal - Stock Titan
BNBX Stock Price and Chart — OTC:BNBX - TradingView
CERo Therapeutics Holdings, Inc. announced that it has received $2.0852 million in funding from SRx Health Solutions Inc. - marketscreener.com
[25-NSE] CERO THERAPEUTICS HOLDINGS, INC. SEC Filing - Stock Titan
Delisting of Securities from The Nasdaq Stock Market - The Manila Times
Nasdaq to delist multiple suspended stocks incl... - pluang.com
Price to earnings forward of CERo Therapeutics Holdings, Inc. – OTC:CERO - TradingView
Price to sales forward of CERo Therapeutics Holdings, Inc. – OTC:CERO - TradingView
Enterprise value to EBITDA forward of CERo Therapeutics Holdings, Inc. – OTC:CERO - TradingView
CERo Therapeutics Amends Convertible Note, Expands Private Financing - TipRanks
CERO Therapeutics (OTCQB: CERO) registers 729.6M shares; files convertible note details - Stock Titan
CERO Therapeutics (CERO) inks $1.41M 10% convertible note with stock conversion - Stock Titan
CERo Therapeutics Holdings, Inc. Actuals & Estimates (OTC:CERO) - TradingView
ADTX Stock Price and Chart — OTC:ADTX - TradingView
CERo Therapeutics Holdings Inc (CERO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CERo Therapeutics Holdings, Inc. announced that it has received $1.4136 million in funding from SRx Health Solutions Inc. - marketscreener.com
CERo Therapeutics Holdings Inc (CEROW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CERo Therapeutics Holdings Inc (CERO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CERo Therapeutics Holdings Inc - TradingKey
CERo Therapeutics Holdings Inc (CERO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CERo Therapeutics Holdings Inc (CERO) Institutional Confidence - TradingKey
CERo Therapeutics Holdings Inc (CERO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CERo Therapeutics Holdings Inc (CERO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CERo Therapeutics Holdings Inc (CERO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CERo Therapeutics Holdings Inc (CERO) Valuation: PE, PB & Fair Value Analysis - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Valuation: PE, PB & Fair Value Analysis - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CERo Therapeutics Holdings Inc (CEROW) Institutional Confidence - TradingKey
Cero Therapeutics Holdings Inc Stock (CERO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
Cap:
|
Volume (24h):